Labcorp falls as 2025 revenue guidance midpoint lowered
Source: SeekingAlpha
2025-10-28 14:12:02 ET
More on Labcorp Holdings
- Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript
- Labcorp Holdings: Currently Priced For Cash And Growth
- Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Labcorp narrows 2025 EPS outlook, targets 8% revenue growth amid restructuring and specialty expansion
- Labcorp Holdings beats bottom-line estimates; updates FY outlook
Read the full article on Seeking Alpha
For further details see:
Labcorp falls as 2025 revenue guidance midpoint lowered
Laboratory Corporation of America Holdings
NASDAQ: LH
LH Trading
-0.41% G/L:
$269.95 Last:
134,453 Volume:
$270 Open:
LH Latest News
February 23, 2026 07:00:00 am
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
LH Stock Data
$23,563,496,000
82,071,000
N/A
505
N/A
Medical Diagnostics & Screening
Healthcare
US
Burlington
